Literature DB >> 29975520

Engineering a Protein Binder Specific for p38α with Interface Expansion.

Mahmud Hussain, Steven P Angus, Brian Kuhlman.   

Abstract

Protein binding specificities can be manipulated by redesigning contacts that already exist at an interface or by expanding the interface to allow interactions with residues adjacent to the original binding site. Previously, we developed a strategy, called AnchorDesign, for expanding interfaces around linear binding epitopes. The epitope is embedded in a loop of a scaffold protein, in our case a monobody, and then surrounding residues on the monobody are optimized for binding using directed evolution or computational design. Using this strategy, we have increased binding affinities by >100-fold, but we have not tested whether it can be used to control protein binding specificities. Here, we test whether AnchorDesign can be used to engineer a monobody that binds specifically to the mitogen-activated protein kinase (MAPK) p38α but not to the related MAPKs ERK2 and JNK. To anchor the binding interaction, we used a small (D) docking motif from the mitogen-activated protein kinase kinase (MAP2K) MKK6 that interacts with similar affinity with p38α and ERK2. Our hypothesis was that by embedding the motif in a larger protein that we could expand the interface and create contacts with residues that are not conserved between p38α and ERK2. Molecular modeling was used to inform insertion of the D motif into the monobody, and a combination of phage and yeast display were used to optimize the interface. Binding experiments demonstrate that the engineered monobody binds to the target surface on p38α and does not exhibit detectable binding to ERK2 or JNK.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29975520      PMCID: PMC6776472          DOI: 10.1021/acs.biochem.8b00408

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Exploring the potential of the monobody scaffold: effects of loop elongation on the stability of a fibronectin type III domain.

Authors:  Vincent Batori; Akiko Koide; Shohei Koide
Journal:  Protein Eng       Date:  2002-12

Review 3.  Protein selection using yeast surface display.

Authors:  Nimish Gera; Mahmud Hussain; Balaji M Rao
Journal:  Methods       Date:  2012-03-23       Impact factor: 3.608

4.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

5.  Limitations of yeast surface display in engineering proteins of high thermostability.

Authors:  Sheldon Park; Yao Xu; Xiaoran Fu Stowell; Feng Gai; Jeffery G Saven; Eric T Boder
Journal:  Protein Eng Des Sel       Date:  2006-03-14       Impact factor: 1.650

Review 6.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

7.  Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency.

Authors:  E V Shusta; M C Kieke; E Parke; D M Kranz; K D Wittrup
Journal:  J Mol Biol       Date:  1999-10-08       Impact factor: 5.469

Review 8.  Mitogen-activated protein kinases in innate immunity.

Authors:  J Simon C Arthur; Steven C Ley
Journal:  Nat Rev Immunol       Date:  2013-08-19       Impact factor: 53.106

9.  Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer.

Authors:  Stephanie Berger; Erik Procko; Daciana Margineantu; Erinna F Lee; Betty W Shen; Alex Zelter; Daniel-Adriano Silva; Kusum Chawla; Marco J Herold; Jean-Marc Garnier; Richard Johnson; Michael J MacCoss; Guillaume Lessene; Trisha N Davis; Patrick S Stayton; Barry L Stoddard; W Douglas Fairlie; David M Hockenbery; David Baker
Journal:  Elife       Date:  2016-11-02       Impact factor: 8.140

Review 10.  Monobodies and other synthetic binding proteins for expanding protein science.

Authors:  Fern Sha; Gabriel Salzman; Ankit Gupta; Shohei Koide
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

View more
  5 in total

1.  Single-domain near-infrared protein provides a scaffold for antigen-dependent fluorescent nanobodies.

Authors:  Olena S Oliinyk; Mikhail Baloban; Charles L Clark; Erin Carey; Sergei Pletnev; Axel Nimmerjahn; Vladislav V Verkhusha
Journal:  Nat Methods       Date:  2022-05-23       Impact factor: 47.990

2.  An improved yeast surface display platform for the screening of nanobody immune libraries.

Authors:  Tomasz Uchański; Thomas Zögg; Jie Yin; Daopeng Yuan; Alexandre Wohlkönig; Baptiste Fischer; Daniel M Rosenbaum; Brian K Kobilka; Els Pardon; Jan Steyaert
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

3.  Optogenetic regulation of endogenous proteins.

Authors:  Taras A Redchuk; Maksim M Karasev; Polina V Verkhusha; Sara K Donnelly; Maren Hülsemann; Jori Virtanen; Henna M Moore; Maria K Vartiainen; Louis Hodgson; Vladislav V Verkhusha
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

Review 4.  Development and Differentiation in Monobodies Based on the Fibronectin Type 3 Domain.

Authors:  Peter G Chandler; Ashley M Buckle
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

5.  Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case.

Authors:  Jiří Zahradník; Gideon Schreiber
Journal:  Biochemistry       Date:  2021-07-01       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.